TCON: TRACON Pharmaceuticals, Inc. Stock

by  •  • Comments Off on TCON: TRACON Pharmaceuticals, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 4.46
Enterprise Value ($M) -4.10
Book Value ($M) -0.81
Book Value / Share -0.36
Price / Book -5.51
NCAV ($M) -1.82
NCAV / Share -0.80
Price / NCAV -2.44

Profitability (mra)
Return on Invested Capital (ROIC) -22.57
Return on Assets (ROA) -0.43
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 0.89
Current Ratio 0.89

Balance Sheet (mrq) ($M)
Current Assets 9.09
Assets 10.11
Liabilities 10.91
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 12.04
Operating Income -6.90
Net Income -3.59
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 3.68
Cash from Investing 0.00
Cash from Financing -12.54

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
04-05 13G/A Ikarian Capital, LLC 5.90 -3.42
03-19 13G/A aaronson wayne 2.30 -59.69
02-14 13G/A Lincoln Park Capital Fund, LLC 0.38 -95.07
02-09 13D/A Opaleye Management Inc. 0.00

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-05 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K
2023-11-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2023-08-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2023-05-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-22 36,051 19,364 186.18
2024-04-19 86,687 39,121 221.59
2024-04-18 91,773 43,566 210.65
2024-04-17 624,448 2,023,692 30.86

(click for more detail)

Similar Companies
SXTC – China SXT Pharmaceuticals, Inc. SXTP – 60 Degrees Pharmaceuticals, Inc.
SYBX – Synlogic, Inc. TCRT – Alaunos Therapeutics, Inc.
TELO – Telomir Pharmaceuticals, Inc.


Financial data and stock pages provided by
Fintel.io